Leukemia patients go 7.6 years before next treatment in AbbVie trial

Leukemia patients go 7.6 years before next treatment in AbbVie trial  Stock Titan

Summary aggregated from Stock Titan's public RSS feed. The full reporting belongs to Stock Titan — please read it on their site.